Could you briefly outline CMIC's profile and its presence in Japan? I can proudly admit that CMIC is the first Contract...
Singapore: A new research study has found deficits in the maturation steps of neurogenesis within the hippocampus of pat...
Singapore: Led by the National Cancer Center of Japan, a joint research pact has been inked by many private companies an...
Regeneron Pharmaceuticals Inc. has announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin Ltd, has receive...
Singapore: Australian drug delivery technology company, Imugene, has received Japanese patent for its novel drug deliver...
Daiichi Sankyo Company Limited has announced that on Friday, June 19, its generics subsidiary, Daiichi Sankyo Espha, wil...
Singapore: Japan's Teikoku Pharma has recieved USFDA approval for Docetaxel injection, a non-alcohol formula for the tre...
Singapore: Sysmex America, and Sysmex, Kobe, Japan, announced that the US FDA has cleared the Sysmex XN-Series Hematolo...
Singapore: Netzsch Japan KK acquired Bruker Corporation's thermal analysis instruments business in Japan. Netzsch Japan ...
Singapore: Boston Scientific has completed enrollment in the SuperNOVA trial - a global, single arm, prospective, multic...
Singapore: A recent report by Research and Markets estimates that global mHealth apps market will reach $6.6 billion in ...
Global biotherapeutics company CSL Behring has submitted its new drug application (NDA) to Japan's Pharmaceuticals and M...
BBK Worldwide, a leading clinical trial marketing firm, has appointed Toshio Mori to Managing Director of Operations, Ja...
W. L. Gore & Associates, Inc. (Gore) has announced that the Food and Drug Administration (FDA) has consented to the ...
Baylor Miraca Genetics Laboratories LLC (BMGL), a joint venture company between Japan-based Miraca Holdings and Baylor C...
Singapore: Global multiple myeloma treatment market value will expand from $7.3 billion in 2014 to $8.9 billion by 2021,...
Singapore: Tokyo-based Teijin Pharma, the core company of the Teijin Group's healthcare business, and Pulmagen Therapeu...
Singapore: Australia-based Cellmid plans to acquire Japanese firm Advangen that owns the FGF-5 inhibitor hair growth tec...
